Chinese manufacturers are supplying large dinghies used by smuggling gangs for migrant crossings across the English Channel, as average boat capacities surge to over 66 people.
African nations such as Zimbabwe, Namibia, and Guinea are banning raw material exports and enforcing local processing, compelling firms to invest in domestic plants.
CXMT, China's leading DRAM maker, is fast-tracked into MSCI's main index 10 days post-IPO, expected to increase passive fund allocations and highlight China's semiconductor industry globally.
Alibaba launched its "most powerful" AI model, Qwen3.8-Max, featuring 2.4 trillion parameters and a 1 million token context window. It demonstrates strong capabilities in coding, research, and visual intelligence, competing with models like Anthropic's Fable 5 and Moonshot AI's Kimi K3.
Beijing has condemned the White House's decision to add 43 Chinese companies to an import blacklist, citing alleged forced labour in Xinjiang. This move, described as "economic coercion" by China, marks the third set of US sanctions against China this week, expanding the entity list under the Uygur Forced Labour Prevention Act.
The White House added 43 Chinese companies to a blacklist under the Uygur Forced Labour Prevention Act, citing alleged forced labor in Xinjiang. Beijing condemned the move as a "classic act of economic coercion," marking the third US measure against China this week.
Chinese stocks trading overseas are emerging as defensive plays for global investors, offering shelter from US equities and bonds due to Federal Reserve monetary policy confusion and a struggling artificial intelligence trade.
The European Union sanctioned 14 Chinese companies for aiding Russia's war, prompting Beijing to retaliate by sanctioning 14 EU defense organizations, including Rheinmetall and a Polish university. China's move, with only one hour's notice, targets EU supply chains with extraterritorial measures, causing concern in Brussels.
China's AI advantage lies in providing capable, affordable intelligence, increasingly capturing market share through cost-effectiveness, reliability, and reach, as seen in OpenRouter's token processing metrics.
European car companies like Volkswagen, BMW, and Mercedes-Benz face significant hurdles in launching robotaxis due to strict regulations, high costs, and cautious software oversight. In contrast, China sees rapid growth in robotaxi services, driven by government support, cheaper hardware, and greater consumer trust.
The UK government nationalized British Steel, previously owned by China's Jingye Group, 15 months after intervening to prevent its closure. China's Ministry of Commerce expressed strong dissatisfaction, stating the move severely undermines Chinese companies' confidence in UK investment and threatens legal action.
AI is moving beyond generating content to "world models" that simulate how the physical or digital world changes. Chinese companies are broadly applying this nascent concept, though its ultimate form remains undefined.
In Johor's state election, voters like Koo prioritize rising living costs and job opportunities over party loyalty or China-linked investments. The focus is on whether the local economy can support residents, with housing prices and cost of living being primary concerns, potentially shifting the traditional Chinese vote.
China's Commerce Minister Wang Wentao urged the Netherlands to create a fair business environment for Chinese companies and resolve disputes involving relevant enterprises during a meeting with Dutch trade minister Sjoerd Sjoerdsma. Both sides aim for a "clean break" from previous frictions, particularly concerning Nexperia.
Chinese AI models from companies like DeepSeek and Z.ai are becoming increasingly popular among U.S. businesses due to their significantly lower costs and competitive performance, narrowing the gap with leading American rivals. This trend is driven by rising token prices for U.S. models and the availability of cheaper open-source alternatives.
The CSRC's IPO approval process prioritizes industries "going global," such as AI, robotics, semiconductors, and biotech, making it easier for them to secure capital. Companies nearing a six-month deadline face application restarts if they fail listing hearings, though lapsed prospectuses don't signify failure if fundamentals remain strong.
A truce in Iran has raised hopes for resuming business, but traders and investors are hesitant. The immediate focus is clearing backlogs of orders disrupted by previous blockades, not new long-term deals.
Morgan Stanley has increased its 2024 forecast for China's humanoid robot shipments to 50,000 units, citing accelerating commercial validation, policy support, and supply-chain momentum. The investment bank also raised its 2030 projection to 446,000 units, with full-sized humanoids expected to dominate the market.
China has placed 10 US companies, including rare-earth firms and defense contractors, on an export control list and barred nearly 50 US companies from government procurement, in response to a US Pentagon blacklist of Chinese firms.
Chinese AI developers are rapidly advancing to trillion-parameter foundation models, aiming to close the gap with US rivals like OpenAI and Anthropic. This push occurs as the US implements export controls restricting access to leading AI software, impacting global availability of top-tier models.
China held a forum in Berlin to promote imports from the EU, aiming to ease trade tensions and address its growing trade surplus. The event, attended by officials and executives, sought to showcase China's market potential amid rising regulatory hurdles and geopolitical shifts in Europe.
China has strongly condemned the UK's imposition of sanctions on four Chinese companies as part of anti-Russian restrictions. The Chinese Embassy in the UK stated that the sanctions lack international legal basis and harm Chinese companies' interests, demanding their immediate revocation.
China's Ministry of Commerce criticized the US for "continuously overstretching the concept of national security" and suppressing Chinese companies, stating these actions harm the global economic order and supply chains.
Chinese biotech companies are pursuing global commercialization despite US regulatory barriers, leveraging cost advantages in markets like Europe. Insilico Medicine's Ren Feng highlighted the need for internationalization and the challenge of lacking overseas clinical teams, suggesting business development deals as a solution.
